Shanghai, China

Linlin Chen

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Journey of Linlin Chen in Pharmaceutical Innovations

Introduction

Linlin Chen, an accomplished inventor located in Shanghai, China, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Chen's work primarily focuses on the development of innovative compounds aimed at addressing serious medical conditions.

Latest Patents

Linlin Chen's latest patents include groundbreaking research on substituted pyrrolo[2,1-f][1,2,4]triazines, which serve as FGFR inhibitors. The first of these patents describes a compound, represented by a specific formula, that is not only innovative but also applicable in treating solid tumors, particularly those associated with FGFR-related diseases. The second patent further discloses the same FGFR inhibitor and emphasizes its use in the preparation of drug formulations for FGFR-related medical conditions. Both patents promise to enhance therapeutic options for patients suffering from various tumors.

Career Highlights

Throughout his career, Linlin Chen has been associated with prominent companies such as Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His tenure at these organizations has enabled him to apply his innovative thinking and research abilities, leading to valuable patents that have the potential to transform the pharmaceutical landscape.

Collaborations

In his professional journey, Linlin Chen has collaborated with notable colleagues like Shuhui Chen and Yikai Wang. These associations underscore the collaborative spirit that drives innovation in research institutions and companies alike.

Conclusion

Linlin Chen's contributions to pharmaceutical innovations through his patents signify a strong commitment to advancing medical science. His work on FGFR inhibitors not only highlights his inventive prowess but also represents a promising step towards effective treatments for serious health conditions. As his career progresses, Linlin Chen remains a vital figure in the realm of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…